ioGlutamatergic Neurons WT (isogenic control) - Human iPSC derived cells
Be the first to review this product! Submit a review
|
(0 Publication)
- Concentration: 1 million cells/vial or 5 million cells/vial
- FuncS
Supplier Data
Functional Studies - ioGlutamatergic Neurons WT (isogenic control) - Human iPSC derived cells (AB303447)
Day 1 to 11 post-thawing; 400X magnification; scale bar : 100µm.
- FuncS
Supplier Data
Functional Studies - ioGlutamatergic Neurons WT (isogenic control) - Human iPSC derived cells (AB303447)
Array Wide Spike Detection Rate histograms (AWSDR – a graphical measure of synchrony) for 10-minute recordings on Day 8, 13 and 20 post-revival ioGlutamatergic Neurons in co-culture with primary rat-derived astrocytes. Results show prominent synchronicity on Day 13, exemplified by the ‘spikier’ nature of the associated AWSDR, which increases at Day 20. Cells were cultured in the recommended open-source medium and recorded on 64-electrode MEAs.
- FuncS
Supplier Data
Functional Studies - ioGlutamatergic Neurons WT (isogenic control) - Human iPSC derived cells (AB303447)
Array Wide Spike Detection Rate histograms (AWSDR – a graphical measure of synchrony) for 10-minute recordings on Day 8, 13 and 20 post-revival ioGlutamatergic Neurons in co-culture with primary rat-derived astrocytes. Results show prominent synchronicity on Day 13, exemplified by the ‘spikier’ nature of the associated AWSDR, which increases at Day 20. Cells were cultured in the recommended open-source medium and recorded on 64-electrode MEAs.
- FuncS
Supplier Data
Functional Studies - ioGlutamatergic Neurons WT (isogenic control) - Human iPSC derived cells (AB303447)
Examples of MaxOne high-resolution multi electrode array (MEA) recordings of ioGlutamatergic Neurons in BrainPhys™ media. The activity maps show firing rate (A), spike amplitude (B) and % of active electrodes (C). Results demonstrate a time-dependent increase of spontaneous activity during neuronal maturation from 2 to 3 weeks post-revival.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - ioGlutamatergic Neurons WT (isogenic control) - Human iPSC derived cells (AB303447)
Immunofluorescent staining on post-revival day 11 demonstrates homogenous expression of pan-neuronal proteins (MAP2 and TUBB3) and glutamatergic neuron-specific transporters (VGLUT1 and VGLUT2). Cells exhibit neurite outgrowth.
- FuncS
Supplier Data
Functional Studies - ioGlutamatergic Neurons WT (isogenic control) - Human iPSC derived cells (AB303447)
(A) The graph shows the % of active bursting electrodes for each time point. (B) An example of a spontaneous spike, taken at Day 8 post-revival (1 second sweep, 32 µV/-18 µV). (C) An example of a bursting phenotype, taken at Day 20 post-revival (1 second sweep, 16 µV/-16 µV). Cells were cultured in the recommended open-source medium and recorded on 64-electrode MEAs.
Reactivity data
Product details
Note that this is suitable for studies with WT Glutamatergic Neurons and also serves as an isogenic control for disease models (HTT, other).
ioGlutamatergic Neurons have been reprogrammed from human induced pluripotent stem cells (iPSC) using opti-ox, a precise reprogramming technology. Human stem cells, within days, convert into consistent, mature, functional glutamatergic neurons providing a high quality human model for the study of neurological activity and disease.
ioGlutamatergic Neurons cultures consist mainly of glutamatergic neurons (>80%) characterised by the expression of the glutamate transporter genes VGLUT1 and VGLUT2 (see Figure 1). The minor remaining fraction of the neuronal population express marker genes of cholinergic neurons. A bulk RNA-seq analysis shows that ioGlutamatergic Neurons have a rostral CNS identity and express the classical cortical maker genes FOXG1 and TBR1 (data not shown).
In partnership with bit.bio
Karyotype: Normal
Seeding Density: 30,000 cells/cm2
Seeding compatibility: 6-, 12-, 24-, 96- and 384-well compatible
Quality control: ICC and gene expression analysis
Research applications: Academic research, Drug development, Neurotoxicology, Genetic screening (e.g. CRISPR screening).
This product is subject to limited use licenses from iPS Academia Japan Inc, TET Systems GmbH, ERS Genomics Limited and Sigma-Aldrich Co. LLC and is developed with Bit Bio patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Handling procedures
Cell culture
Biosafety level
EU: 1 US: 1
Gender
Male
Viability
> 85%
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Complementary Products
Primary Antibodies
AB8227
Anti-beta Actin antibody - Loading Control
BOND RX™ Validated|Lab Essentials
- 5
- 104
Cell Lines & Lysates
AB307781
ioGlutamatergic Neurons TDP-43 M337V homozygous - Human iPSC derived cells
- 0
- 0
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com